ISSN:

Journal Home

Journal Guideline

Molecular Cancer Therapeutics Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 190. It has a price of 3000 €. It has an SJR impact factor of 1,89 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,89.

Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, cancer, potent, cells, protein, resistance, activity, receptor, inhibition, vitro, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

3000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,89

SJR Impact factor

190

H Index

170

Total Docs (Last Year)

698

Total Docs (3 years)

7123

Total Refs

3947

Total Cites (3 years)

687

Citable Docs (3 years)

5.38

Cites/Doc (2 years)

41.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals